Daivonex® is a topical formulation of the
vitamin D derivative, calcipotriol, which induces
differentiation and suppresses proliferation of skin
cells (keratinocytes). Daivonex® thus normalises
abnormal cell proliferation and differentiation in
psoriatic skin.

Indications:
Psoriasis vulgaris.

Daivonex® ointment should not be used in the face
since the ointment formulation may give rise to
irritation of the facial skin.
Careful handwashing after use is recommended.

Daivonex® ointment should be applied sparingly
to the affected skin lesions twice daily. For some
patients the maintenance therapy may be achieved
with less frequent application. The weekly dose
should not exceed 100 g.

Minor adverse effects such as transient local irritation
and, very rarely, facial dermatitis may occur.

Store at controlled room temperature (15-25 degrees)